The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
Australia's taken another step in HIV prevention, with the TGA approving long-acting drug lenacapavir—but access is vital, ...
Though an antiretroviral medication called PrEP provides near-perfect protection against HIV, patients must often surmount ...
Nationwide, an estimated 1.2 million people are eligible to receive medication that can prevent the spread of life-threatening HIV infection. But only roughly a third of those eligible are currently ...
About 36,000 Americans develop HIV each year, according to the Centers for Disease Control and Prevention. And while there is a new FDA-approved medication (Apretude, approved in 2021) to treat those ...
It’s been over a decade since the Food and Drug Administration first approved a medication to prevent HIV. But the Centers for Disease Control and Prevention estimates just 30% of the 1.2 million ...
The Food and Drug Administration approved the use of PrEP, short for pre-exposure prophylaxis, as a strategy to prevent people from contracting HIV in 2012. Some were eager to take advantage of the ...
Pharmaceutical Technology on MSN
UK approves Gilead’s twice-yearly HIV PrEP drug
Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option for HIV, offering patients a twice-yearly injection to reduce the risk of ...
The Food and Drug Administration approved the use of PrEP, short for pre-exposure prophylaxis, as a strategy to prevent people from contracting HIV in 2012. Some were eager to take advantage of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback